Developing Non-Communicable Disease Registries in Africa : A Step Towards Providing Quality Data for Improving Patient Outcomes

Enrolling by invitationOBSERVATIONAL
Enrollment

7,566

Participants

Timeline

Start Date

March 16, 2018

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Non-Communicable Disease
Interventions
BEHAVIORAL

Questionnaire forms

The questionnaires will include information such as socio-demographic data, risk factors, disease specific data, investigation and treatment details as well as findings during followup. Particular reference will be made to outcome measures such as local and distant recurrence, survival and mortality.

OTHER

Bio-specimen samples

Samples can include tissue, blood, urine, saliva, hair and nail clipping.

Trial Locations (14)

10065

Memorial Sloan Kettering Cancer Center, New York

600104

University of Maiduguri Teaching Hospital (Data collection only), Maiduguri

900103

National Hospital of Abuja (Data collection only), Abuja

Unknown

Lagos State University Teaching Hospital, Idi-Araba

Olabisis Onabanjo University Teaching Hospital, Sagamu

Federal Medical Centre Owo, Owo

University College Hospital, Ibadan

Ladoke Akintola University of Technology, Ogbomoso

University Of Nigeria Teaching Hospital (UNTH) Ituku-Ozalla Enugu, Enugu

Lagos State University Teaching Hospital, Ikeja

Obafemi Awolowo University Teaching Hospitals Complex (OAUTHC), Ile-Ife

University of Ilorin Teaching Hospitals, Ilorin

Ondo State Trauma and Surgical Centre, Ondo

Federal Medical Centre Owo, Owo

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Duke University

OTHER

collaborator

Johns Hopkins University

OTHER

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT03473795 - Developing Non-Communicable Disease Registries in Africa : A Step Towards Providing Quality Data for Improving Patient Outcomes | Biotech Hunter | Biotech Hunter